Overview

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy of diet and exercise (DE), with and without niacin and fenofibrate, in reducing the cardiovascular risk of patients with HIV lipodystrophy or dyslipidemia.

Phase:

N/A

Details

Lead Sponsor:

Baylor College of Medicine

Collaborators:

Legacy Community Health Center
National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Fenofibrate
Niacin
Niacinamide
Nicotinic Acids